Siemens is improving diagnosis and treatment of diseases with a unique imaging system that locates metabolic processes using nuclear detectors and x-ray images with high accuracy.
Symbia IntevoTM*, the world's first xSPECT* system, integrates metabolic information from single photon emission computed tomography (SPECT) into computed tomography (CT) images.
Previously, SPECT/CT images had low spatial resolution and physicians needed extensive experience and additional follow-up studies to decide whether a metabolic anomaly reflected a tumor or other diseases. Symbia Intevo also enables physicians to determine tumor size and thus plan treatment and monitor outcomes.
During SPECT examinations, patients are given low doses of radiopharmaceuticals that emit radiation when they react with a particular body tissue. Different metabolic processes can thus be observed depending on the agent administered. To determine the location of a metabolic disorder in the body, SPECT information is overlaid with CT images showing the anatomy of the body.
Until now, the problem has been that SPECT examinations offer only low spatial resolution and the high-precision CT images have to be adapted to match them. It can happen that the resulting image no longer clearly shows whether the metabolic disorder observed is inside or outside the bone. It would initially be unclear whether the anomaly was caused by a tumor in the bone or something else, such as a soft tissue inflammation.
The developers at Siemens Healthcare have now integrated SPECT and CT data in such a way that the high spatial resolution of the x-ray images remains intact and the SPECT images are significantly improved. The two datasets are generated sequentially during reconstruction in the same device using reference parameters such as the position of the detectors relative to the patient.
New, iterative image reconstruction algorithms refine the data in several passes. It was not previously possible to perform such complex calculation processes at the high resolution used in the CT images. That's why, in addition to new software, Symbia Intevo is also equipped with a powerful 64-bit computer.
The precise xSPECT data also makes it possible to determine the volume of the radiopharmaceutical used. This means that physicians can observe the change in metabolic activity and check whether their treatment is working.
Symbia Intevo also utilizes state-of-the-art algorithms that use the CT measurements to assign each voxel (three-dimensional pixel) in the xSPECT image to a particular class-fatty tissue, soft tissue, air, or hard (external) and soft (internal) bone areas. This makes it easy to recognize the body part where the metabolic disorder is located.
* Symbia Intevo and xSPECT are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed.
Dr. Norbert Aschenbrenner | Siemens InnovationNews
Innovative device allows 3-D imaging of the breast with less radiation
17.06.2016 | DOE/Thomas Jefferson National Accelerator Facility
The vascular bypass revolution
13.06.2016 | Université de Genève
3D printing revolutionized the manufacturing of complex shapes in the last few years. Using additive depositing of materials, where individual dots or lines...
R2D2, a joint project to analyze and development high-TRL processes and technologies for manufacture of flexible organic light-emitting diodes (OLEDs) funded by the German Federal Ministry of Education and Research (BMBF) has been successfully completed.
In contrast to point light sources like LEDs made of inorganic semiconductor crystals, organic light-emitting diodes (OLEDs) are light-emitting surfaces. Their...
High resolution rotational spectroscopy reveals an unprecedented number of conformations of an odorant molecule – a new world record!
In a recent publication in the journal Physical Chemistry Chemical Physics, researchers from the Max Planck Institute for the Structure and Dynamics of Matter...
Strands of cow cartilage substitute for ink in a 3D bioprinting process that may one day create cartilage patches for worn out joints, according to a team of engineers. "Our goal is to create tissue that can be used to replace large amounts of worn out tissue or design patches," said Ibrahim T. Ozbolat, associate professor of engineering science and mechanics. "Those who have osteoarthritis in their joints suffer a lot. We need a new alternative treatment for this."
Cartilage is a good tissue to target for scale-up bioprinting because it is made up of only one cell type and has no blood vessels within the tissue. It is...
Physicists in Innsbruck have realized the first quantum simulation of lattice gauge theories, building a bridge between high-energy theory and atomic physics. In the journal Nature, Rainer Blatt‘s and Peter Zoller’s research teams describe how they simulated the creation of elementary particle pairs out of the vacuum by using a quantum computer.
Elementary particles are the fundamental buildings blocks of matter, and their properties are described by the Standard Model of particle physics. The...
28.06.2016 | Event News
09.06.2016 | Event News
24.05.2016 | Event News
29.06.2016 | Life Sciences
29.06.2016 | Life Sciences
29.06.2016 | Physics and Astronomy